Valuation: Dechra Pharmaceuticals

Market Cap 440.36Cr 588.68Cr 513.06Cr 479.07Cr 826.23Cr 56TCr 846.05Cr 5.68TCr 2.22TCr 28TCr 2.21TCr 2.16TCr 96TCr P/E 2022
64.8x
P/E 2023 -150x
Enterprise Value 483.37Cr 646.17Cr 563.17Cr 525.86Cr 906.93Cr 62TCr 928.68Cr 6.23TCr 2.43TCr 31TCr 2.42TCr 2.37TCr 1,05600Cr EV / Sales 2022
5.8x
EV / Sales 2023 6.08x
Free-Float
-
Yield 2022
1.3%
Yield 2023 0.34%
3 years 3,644
Extreme 3644
3,868
5 years 2,473.32
Extreme 2473.323
5,525
10 years 1,225
Extreme 1225
5,525
Manager TitleAgeSince
Chief Executive Officer - 10/06/2024
Director of Finance/CFO 46 03/04/2019
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 46 30/10/2019
Director/Board Member 68 01/12/2016
Director/Board Member 59 01/02/2019
Date Insider Type Main position Quantity % Market Cap.
15/01/24 Buy

Chief Executive Officer

155 0.0001%
15/01/24 Buy

Chief Executive Officer

627 0.0006%
15/01/24 Free

Chief Executive Officer

20,193 0.0177%

Financials

2022 2023
Net sales 68Cr 91Cr 79Cr 74Cr 127.92Cr 8.69TCr 130.99Cr 879.04Cr 343.11Cr 4.32TCr 341.75Cr 334.64Cr 15TCr 76Cr 101.8Cr 89Cr 83Cr 142.88Cr 9.71TCr 146.3Cr 981.79Cr 383.22Cr 4.82TCr 381.69Cr 373.76Cr 17TCr
Net income 5.82Cr 7.78Cr 6.78Cr 6.33Cr 11Cr 742.15Cr 11Cr 75Cr 29Cr 368.67Cr 29Cr 29Cr 1.27TCr -2.79Cr -3.73Cr -3.25Cr -3.04Cr -5.23Cr -355.77Cr -5.36Cr -36Cr -14Cr -176.73Cr -14Cr -14Cr -609.46Cr
Net Debt 21Cr 28Cr 24Cr 23Cr 39Cr 2.65TCr 40Cr 268.43Cr 104.77Cr 1.32TCr 104.36Cr 102.19Cr 4.55TCr 43Cr 57Cr 50Cr 47Cr 81Cr 5.48TCr 83Cr 554.52Cr 216.44Cr 2.72TCr 215.58Cr 211.1Cr 9.4TCr
Logo Dechra Pharmaceuticals
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Employees
-
Sector
-